•  
  •  
 

Abstract

Objectives: The purpose of this study was to analyze and evaluate evidence supporting curcumin lowering the systemic inflammatory marker, CRP in humans. Methods: A systematic literature search was completed using PubMed and MEDLINE databases. Results: After inclusion and exclusion criteria, 9 studies were evaluated, and the percent change of CRP blood levels was calculated and analyzed. Results: The results for these studies show strong statistical significance for the C3 complex with Bioperine and nano curcumin. Bioactive curcumin exhibits a higher percent decrease of blood level CRP than trials using only curcumin or turmeric. Conclusion: Overall bioactive curcumin/ curcumin with Bioperine are alternative treatments for lowering the systemic inflammation marker, CRP.

Author Bio(s)

Lauren Katakowski is a Master's student at Central Michigan University, in the program of Nutrition and Dietetics.

Susan Hewlings, Ph.D., RD, is a professor at Central Michigan University for the Nutrition and Dietetics program.

Acknowledgements

Margret Danowski, Health Professions Librarian, Central Michigan University, for her assistance with the literature search.

DOI

10.46743/1540-580X/2022.2182

Share

 
COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.